We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-16.17%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$212B
AUM Growth
-$75.2B
Cap. Flow
-$21.6B
Cap. Flow %
-10.18%
Top 10 Hldgs %
16.53%
Holding
8,948
New
748
Increased
2,253
Reduced
4,775
Closed
880

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$828M
2
AAPL icon
Apple
AAPL
+$800M
3
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$654M
4
BA icon
Boeing
BA
+$592M
5
JPM icon
JPMorgan Chase
JPM
+$416M

Sector Composition

Rank Sector Weight
1 Technology 10.37%
2 Healthcare 6.89%
3 Financials 5.79%
4 Consumer Discretionary 5.66%
5 Communication Services 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNDA icon
6326
Vanda Pharmaceuticals
VNDA
$299M
$26K ﹤0.01%
2,555
-72,624
-97% -$900K
WERN icon
6327
Werner Enterprises
WERN
$2.15B
$26K ﹤0.01%
717
-8,925
-93% -$321K
VIVS
6328
VivoSim Labs
VIVS
$1.23M
$26K ﹤0.01%
258
-104
-29% -$8.39K
PETQ
6329
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$26K ﹤0.01%
1,153
-1,307
-53% -$36.3K
OPGN
6330
DELISTED
OpGen, Inc
OPGN
$26K ﹤0.01%
+52
New +$21.7K
CHNA
6331
DELISTED
Loncar China BioPharma ETF
CHNA
$26K ﹤0.01%
1,148
+416
+57% +$10.3K
SOLY
6332
DELISTED
Soliton, Inc.
SOLY
$26K ﹤0.01%
3,227
-3,614
-53% -$40.8K
AMHCU
6333
DELISTED
Amplitude Healthcare Acquisition Corporation Unit
AMHCU
$26K ﹤0.01%
2,635
-600
-19% -$6.11K
UJPY
6334
DELISTED
Exchange-Traded Notes linked to the VelocityShares Daily 4X Long JPY vs. USD Index due December 6, 2
UJPY
$26K ﹤0.01%
1,124
+114
+11% +$2.61K
CHK
6335
PUT
DELISTED
Chesapeake Energy Corporation
CHK
$26K ﹤0.01%
750
ASEA icon
6336
Global X FTSE Southeast Asia ETF
ASEA
$102M
$25K ﹤0.01%
2,223
-132
-6% -$1.86K
ATNM icon
6337
Actinium Pharmaceuticals
ATNM
$24.8M
$25K ﹤0.01%
4,361
-1,472
-25% -$10.5K
AZUL
6338
DELISTED
Azul
AZUL
$25K ﹤0.01%
2,458
-6,096
-71% -$193K
CXT icon
6339
PUT
Crane NXT
CXT
$2.96B
$25K ﹤0.01%
1,440
+576
+67% +$14.8K
KEQU icon
6340
Kewaunee Scientific
KEQU
$104M
$25K ﹤0.01%
3,084
+234
+8% +$2.59K
KORU icon
6341
Direxion Daily MSCI South Korea Bull 3X ETF
KORU
$1.38B
$25K ﹤0.01%
+6,530
New +$62.3K
KZIA
6342
Kazia Therapeutics
KZIA
$158M
$25K ﹤0.01%
173
+142
+458% +$28.1K
MIST icon
6343
Milestone Pharmaceuticals
MIST
$156M
$25K ﹤0.01%
+13,499
New +$234K
OVB icon
6344
Overlay Shares Core Bond ETF
OVB
$47.8M
$25K ﹤0.01%
+983
New +$24.9K
PFIG icon
6345
Invesco Fundamental Investment Grade Corporate Bond ETF
PFIG
$117M
$25K ﹤0.01%
998
+644
+182% +$16.8K
RYLD icon
6346
Global X Russell 2000 Covered Call ETF
RYLD
$1.39B
$25K ﹤0.01%
+1,435
New +$32.7K
WBIY icon
6347
WBI Power Factor High Dividend ETF
WBIY
$62.4M
$25K ﹤0.01%
1,676
-1,004
-37% -$22.9K
ISZE
6348
DELISTED
iShares MSCI Intl Size Factor ETF
ISZE
$25K ﹤0.01%
1,198
-156
-12% -$3.96K
FLFR
6349
DELISTED
Franklin FTSE France ETF
FLFR
$25K ﹤0.01%
1,324
-246
-16% -$5.91K
NOVN
6350
DELISTED
Novan, Inc. Common Stock
NOVN
$25K ﹤0.01%
5,199
+5,039
+3,149% +$28.6K

Similar funds

UBS Group's Q1 2020 Portfolio in Review

As of Q1 2020, UBS Group held 8,948 positions worth $212B, down 26% from $287B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

UBS Group withdrew a net $21.6B in Q1 2020, closing 880 positions and reducing 4,775 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $196M position sold in full.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.8% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS Group opened a new position in VelocityShares Daily 2x VIX Short Term ETN worth $221M.

  • UBS Group's largest Q1 2020 buy was VelocityShares Daily 2x VIX Short Term ETN: 705,722 shares worth $221M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $834M increase.
  • UBS Group's biggest Q1 2020 reduction was Microsoft, cutting an estimated $828M.
  • UBS Group fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $196M.
  • UBS Group's ten largest holdings make up 17% of its $212B portfolio in Q1 2020.
  • UBS Group opened 748 new positions and closed 880 in Q1 2020.
  • UBS Group's portfolio value fell 26% quarter-over-quarter to $212B.

Based on UBS Group's 13F filing for Q1 2020, filed 1 May 2020.